GlassScriptPhysician profile
Joel D Epstein
NPI 1013037779
$4,721.69
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,848 · 2020: $1,130 · 2021: $1,307 · 2022: $339 · 2023: $98.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,006.87 | 2019-2022 | |
| Glaxosmithkline, LLC. | $740.99 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $712.30 | 2019-2021 | |
| Allergan, INC. | $613.83 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $412.05 | 2019-2021 | |
| Mylan Specialty L.P. | $400.47 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $171.31 | 2021-2023 | Dupixent |
| Philips North America LLC | $107.38 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $88.68 | 2019-2022 | |
| Genzyme Corporation | $69.94 | 2021-2022 | |
| Advanced Respiratory, INC | $58.17 | 2020 | |
| Sunovion Pharmaceuticals INC. | $54.50 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $47.17 | 2019-2022 | |
| Electromed, INC. | $40.58 | 2023 | Smartvest |
| United Therapeutics Corporation | $35.87 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $28.86 | 2022 | |
| Gilead Sciences, INC. | $24.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.79 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.72 | 2021 | |
| Baxter Healthcare | $19.98 | 2023 | Hillrom - Life 2000 Ventilation System |
| Teva Pharmaceuticals USA, INC. | $13.53 | 2021 | |
| Abbvie INC. | $13.13 | 2023 | |
| Circassia INC. | $11.50 | 2019 | |
| Inogen, INC. | $6.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.